<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lou J</submitter><funding>Ningbo Top Medical and Health Research Program</funding><funding>NINGBO Leading Medical &amp; Health Discipline</funding><funding>HwaMei Reasearch Foundation of Ningbo No.2 Hospital</funding><pagination>e13820</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11186709</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>30(6)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Successful usage of autologous skin cell suspension (ASCS) has been demonstrated in some clinical trials. However, its efficacy and safety have not been verified. This latest systematic review and meta-analysis aim to examine the effects of autologous epidermal cell suspensions in re-epithelialization of skin lesions.&lt;h4>Methods&lt;/h4>Relevant articles were retrieved from PubMed, Embase, Cochrane Database, Web of Science, International Clinical Trials Registry Platform, China National Knowledge Infrastructureris, VIP Database for Chinese Technical Periodicals and Wanfang database. The primary output measure was the healing time, and the secondary outputs were effective rate, size of donor site for treatment, size of study treatment area, operation time, pain scores, repigm</pubmed_abstract><journal>Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)</journal><pubmed_title>The efficacy and safety of autologous epidermal cell suspensions for re-epithelialization of skin lesions: A systematic review and meta-analysis of randomized trials.</pubmed_title><pmcid>PMC11186709</pmcid><funding_grant_id>2022-F17</funding_grant_id><funding_grant_id>2022HMKY48</funding_grant_id><funding_grant_id>2023030615</funding_grant_id><pubmed_authors>Jin G</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Fan Y</pubmed_authors><pubmed_authors>Xiang Z</pubmed_authors><pubmed_authors>Huang N</pubmed_authors><pubmed_authors>Cui S</pubmed_authors><pubmed_authors>Song J</pubmed_authors><pubmed_authors>Lou J</pubmed_authors></additional><is_claimable>false</is_claimable><name>The efficacy and safety of autologous epidermal cell suspensions for re-epithelialization of skin lesions: A systematic review and meta-analysis of randomized trials.</name><description>&lt;h4>Background&lt;/h4>Successful usage of autologous skin cell suspension (ASCS) has been demonstrated in some clinical trials. However, its efficacy and safety have not been verified. This latest systematic review and meta-analysis aim to examine the effects of autologous epidermal cell suspensions in re-epithelialization of skin lesions.&lt;h4>Methods&lt;/h4>Relevant articles were retrieved from PubMed, Embase, Cochrane Database, Web of Science, International Clinical Trials Registry Platform, China National Knowledge Infrastructureris, VIP Database for Chinese Technical Periodicals and Wanfang database. The primary output measure was the healing time, and the secondary outputs were effective rate, size of donor site for treatment, size of study treatment area, operation time, pain scores, repigm</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2026-05-03T03:25:04.71Z</modification><creation>2026-04-07T18:47:27.723Z</creation></dates><accession>S-EPMC11186709</accession><cross_references><pubmed>38898373</pubmed><doi>10.1111/srt.13820</doi></cross_references></HashMap>